The main challenges facing the application of siRNA therapeutics include the stability and effective delivery of siRNA in vivo. Important advances in nanotechnology have greatly facilitated the development of efficient siRNA delivery systems.
Relying on state-of-the-art biochemical facilities and years of experience in providing high-quality bioconjugate complexes, BOC RNA can provide you with custom nanoparticle-siRNA conjugate services with flexibility, repeatability and quality assurance.
